Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02121548 · ClinicalTrials.gov registry record · NA

Using CHWs and HPV Home Tests to Increase Cervical Cancer Screening in Minority Populations

A NA study, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
601
Enrollment target

NCT02121548: Completed NA study, sponsored by University of Miami.

NCT02121548 is a NA study that has completed, run by University of Miami. The registered enrollment target is 601 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02121548, a NA study, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
601 participants
Enrollment target

Study Summary

Caribbean immigrants (both Hispanics and Blacks from Haiti) are less likely to be screened for cervical cancer than the general population. One promising approach is outreach strategies that employ Community Health Workers (CHWs). Yet even in well structured CHW programs, many women remain unscreened. In our NCI Community Networks sponsored project, we are testing an approach that combines CHWs with self sampling for the human papilloma virus (HPV) as a screening strategy among such hard to reach populations.

Primary Outcome

Primary Outcome: The primary outcome is patient self-reporting on whether they had a Pap smear of HPV testing done since the initial evaluation. As an additional analysis, patients whom were contacted by phone but do no wish to return for follow-up evaluation will be asked by phone if they had the Pap Smear of HPV testing done.

Interventions

  • BEHAVIORAL CHW Outreach and HPV Self-sampling
  • BEHAVIORAL CHW Outreach

Trial Details

FieldValue
Enrollment Target 601 participants
Start Date 2011-10-10
Est. Completion 2015-02-17
Phase NA
University of Miami

721 total trials

What the finished NCT02121548 record still lists

NCT02121548 is an interventional study that assigns participants to a tested intervention. The registered 601 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).

The record links to 0 conditions, and to 2 interventions - of which CHW Outreach and HPV Self-sampling is the first listed.

NCT02121548 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02121548 about?

NCT02121548 is a clinical study titled "Using CHWs and HPV Home Tests to Increase Cervical Cancer Screening in Minority Populations". Caribbean immigrants (both Hispanics and Blacks from Haiti) are less likely to be screened for cervical cancer than the general population. One promising approach is outreach strategies that employ Community Health Workers (CHWs). Yet even in well structured CHW programs, many women remain unscreene...

What is the current status of trial NCT02121548?

This trial is currently completed. It is a NA study. The enrollment target is 601 participants. The study started on 2011-10-10. Estimated completion is 2015-02-17.

What interventions are being tested in trial NCT02121548?

The interventions under investigation include: CHW Outreach and HPV Self-sampling (BEHAVIORAL), CHW Outreach (BEHAVIORAL).

Who is sponsoring clinical trial NCT02121548?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02121548's enrollment target sits among peer trials

601 162nd of 2000 higher than 1,839 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02121548, the US trial registry maintained by the National Library of Medicine. NCT02121548 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.